权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Molecular and Cellular Biology of Thrombopoietin

血小板生成素的分子和细胞生物学

基本信息

批准号：
8496504
负责人：
AMY E GEDDIS
金额：
$ 31.89万
依托单位：
STATE UNIVERSITY NEW YORK STONY BROOK
依托单位国家：
美国
项目类别：
财政年份：
1995
资助国家：
美国
起止时间：
1995-06-01 至 2015-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8496504
关键词：
Accounting Benign Binding Blood Platelets Cell Differentiation process Cell Line Cell Survival Cells Congenital Disorders Development Endocytosis Endosomes Erythroid Cells Erythropoiesis Erythropoietin Erythropoietin Receptor Etiology Financial compensation Health Hemorrhagic Thrombocythemia Knockout Mice Ligands Link Lysosomes MAP Kinase Gene Measures Megakaryocytopoieses Modeling Molecular and Cellular Biology Mus Mutate Mutation Myeloproliferative disease Pathway interactions Patients Peptides Phosphorylation Phosphotyrosine Physiology Platelet Count measurement Polycythemia Vera Primary Myelofibrosis Process Production Proteins Recycling Regulation Residual state Role Signal Transduction Surface Thrombocytopenia Thrombopoiesis Thrombopoietin Tyrosine Ubiquitination Work cancer cell cell growth regulation cytokine glycosylation human MPL protein insight leukemia loss of function mimetics multicatalytic endopeptidase complex neoplastic prevent progenitor protein protein interaction receptor receptor sensitivity response src Homology Region 2 Domain tool trafficking

项目摘要

DESCRIPTION (provided by applicant): Thrombopoietin (TPO) is the primary regulator of thrombopoiesis. Through its interaction with the c-Mpl receptor, TPO initiates a signaling cascade by triggering the phosphorylation and activation of Jak2. Although this is well established, it remains unclear as to how TPO signaling is modulated, which has important consequences for the regulation of cell growth and differentiation. Dysregulation of TPO signaling, as exemplified by mutations conferring constitutive activity to Jak2 or c-Mpl, is known to underlie the development of congenital and acquired myeloproliferative disorders (MPDs), including polycythemia vera (PV), essential thrombocythemia (ET) and idiopathic myelofibrosis (IMF). In addition, TPO-mimetics are emerging as important tools for the treatment of patients with thrombocytopenia of both benign and neoplastic etiologies. In this competitive renewal we propose to study the regulation of TPO signaling, including: 1) c-Mpl receptor trafficking and internalization in response to TPO, 2) regulation of c-Mpl degradation and its consequences for TPO signaling, and 3) functional similarities and differences between TPO and erythropoietin (EPO) signaling.

说明(申请人提供)：血小板生成素(TPO)是血小板生成的主要调节因子。通过与c-MPL受体的相互作用，TPO启动了JAK2的磷酸化和激活，从而启动了一系列信号级联反应。尽管这一点已经得到了很好的证实，但TPO信号是如何调节的仍然不清楚，它对细胞生长和分化的调节具有重要的后果。以JAK2或c-MPL结构活性突变为代表的TPO信号失控是先天性和获得性骨髓增生性疾病(MPD)的基础，包括真性红细胞增多症(PV)、原发性血小板增多症(ET)和特发性骨髓纤维化(IMF)。此外，TPO类似物正在成为治疗良性和肿瘤性血小板减少症患者的重要工具。在这一竞争性更新中，我们建议研究TPO信号的调节，包括：1)TPO反应中c-MPL受体的运输和内化，2)c-MPL降解的调节及其对TPO信号的影响，以及3)TPO和促红细胞生成素(EPO)信号的功能异同。